Navigation Links
Roche Madison Moves to New Facility
Date:4/23/2009

- State-of-the-art facility designed to foster drug delivery -

MADISON, Wis. and NUTLEY, N.J., April 23 /PRNewswire/ -- Today, Roche Madison Inc. officially opened the doors to a new state-of-the-art facility with chemistry and biology labs at the University of Wisconsin Research Park in Madison. Part of the global RNA Therapeutics group within Roche, the group's research focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform. RNAi - a natural mechanism that the body uses to 'silence' certain genes - represents a potential whole new class of therapeutics for difficult to treat diseases. The site currently has a 45-member staff and plans to hire additional staff during the next six to 12 months as part of its planned expansion.

In 2008, Roche purchased Mirus Bio Corporation, a leader in the fields of RNA interference and gene therapy, which became Roche Madison. "We are very pleased to be a vital part of the Roche RNA Therapeutics program and our new facilities will help ensure that we can continue to develop our technology in the most advantageous manner for targeted drug delivery," said Jim Hagstrom, vice president, Operations, Roche Madison. "As one of the few pharmaceutical sites in the state, we look forward to remaining a vital part of the Madison landscape and to finding innovative ways of getting RNAi therapeutics into specific disease targets to benefit patients."

"The presence of the new Roche research site within the University of Wisconsin Research Park represents a win/win situation for both Roche employees and for the Madison economy overall - and it further validates that the high quality research being performed by the Madison scientific community is being recognized by the world's lea
'/>"/>

SOURCE Roche Madison Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services
2. Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU
3. Roche Completes Tender Offer for Genentech
4. Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
5. SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
6. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
7. Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
8. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
9. Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.
10. Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
11. InformationWeek Puts Roche Diagnostics on Top 500 Innovative Tech Users List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, ... webcast of a presentation to investors on Tuesday, ... p.m. PDT.  The presentation will include an overview ... To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... computers have yet to materialise. Yet, scientists are ... such computers faster. One such approach relies on ... by applying an electric field. A new study ... coupled quantum dots (TQDs) with electrical impulses can ... example, should TQDs be used as quantum information ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... Angiotech Pharmaceuticals, Inc. ("Angiotech") (NASDAQ: ANPI , ... meeting of shareholders will take place on June 4, ... Grand Vancouver, 403 Robson Street, Vancouver, BC V6B 6L9. ... of and vote at the meeting will be April ...
... be invested in the first phase of this personalized ... National Functional Genomics Center , funded ... by the U.S. Army Medical Research & ... Telemedicine & Advanced Technology Research Center (TATRC), ...
... SILVER SPRING, Md., April 24 United Therapeutics Corporation ... will release its 2009 first quarter financial results before ... host a half-hour teleconference on Friday, May 1, 2009, ... accessible by dialing 877-718-5092, with international callers dialing 719-325-4795. ...
Cached Biology Technology:NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer 2NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer 3
(Date:7/25/2014)... Boston, MA A study published online in the ... describes a novel approach to preventing cervical cancer based ... cervical cancer after removal of a discrete population of ... from a study that looked at squamocolumnar junction cells, ... canal and have been implicated as the origins of ...
(Date:7/25/2014)... characterized by the existence of numerous isoforms arising ... the protein deeply different characteristics. NRG1 plays an ... development and the different phases occurring after injury ... remyelination and target reinnervation, Researchers at the University ... NRG1 upregulation observed in Schwann cells immediately after ...
(Date:7/25/2014)... use of a molecular testing panel developed at ... correct initial surgery for patients with thyroid nodules ... Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter., ... Center and other diagnostic testing agencies, improved the ... by 30 percent, according to the study published ...
Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3
... A major international study with leadership from Massachusetts General ... associated with blood sugar or insulin levels. Two ... associated with glucose levels were also found to increase ... a related study from members of the same research ...
... a team of researchers is releasing data today that it ... the family of parasites that causes a deadly trio of ... nations for centuries. In an article to be published ... , Vanderbilt University scientist Galina Lepesheva and her team are ...
... A breakthrough discovery by scientists at the University of Kentucky ... diseases of the brain, spinal cord and the eye. ... visual science in the UK College of Medicine, found that ... proteins vimentin and glial fibrillary acidic protein (GFAP) ...
Cached Biology News:New gene variants associated with glucose, insulin levels, some with diabetes risk 2Scientists hope to end sleeping sickness by making parasite that causes it self-destruct 2Scientists hope to end sleeping sickness by making parasite that causes it self-destruct 3Kentucky study advances new target for CNS drug development 2
Human Aminopeptidase P1/XPNPEP1 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Template and primers for preparation of internal control spots...
Cross reactivity to St. Louis encephalitis (MSI-7) is determined by ELISA....
...
Biology Products: